TLR and NKG2D Signaling Pathways Mediate CS-Induced Pulmonary Pathologies

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Wortham, Brian W ^a   Eppert, Bryan L ^a   Flury, Jennifer L ^a   Morgado Garcia, Sara ^a   Borchers, Michael T ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE PROTEIN; CIGARETTE SMOKE; NATURAL KILLER CELL RECEPTOR NKG2D; NUCLEIC ACID; RETINOIC ACID INDUCIBLE EARLY TRANSCRIPT 1; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG;

AIRWAY REMODELING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL SURFACE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; LUNG DISEASE; LUNG FLUID; MOUSE; NATURAL KILLER CELL; NONHUMAN; PNEUMONIA; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANIMALS; CELL LINE; FEMALE; HUMANS; KILLER CELLS, NATURAL; LUNG; MICE; MICE, INBRED C57BL; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; PNEUMONIA; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKE; TOBACCO; TOLL-LIKE RECEPTORS;

EID: 84885146607     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0078735     Document Type: Article

References (40)

1. Pauwels R, (2001) Global initiative for chronic obstructive lung diseases (GOLD): time to act. Eur Respir J 18: 901-902. doi:10.1183/09031936.01.0027401. PubMed: 11829093.
2. Brusselle GG, Joos GF, Bracke KR, (2011) New insights into the immunology of chronic obstructive pulmonary disease. Lancet 378: 1015-1026. doi:10.1016/S0140-6736(11)60988-4. PubMed: 21907865.
3. Borchers MT, Wesselkamper SC, Curull V, Ramirez-Sarmiento A, Sánchez-Font A, et al. (2009) Sustained CTL activation by murine pulmonary epithelial cells promotes the development of COPD-like disease. J Clin Invest 119: 636-649. doi:10.1172/JCI34462. PubMed: 19197141.
4. Motz GT, Eppert BL, Wortham BW, Amos-Kroohs RM, Flury JL, et al. (2010) Chronic cigarette smoke exposure primes NK cell activation in a mouse model of chronic obstructive pulmonary disease. J Immunol 184: 4460-4469. doi:10.4049/jimmunol.0903654. PubMed: 20228194.
5. Wortham BW, Eppert BL, Motz GT, Flury JL, Orozco-Levi M, et al. (2012) NKG2D mediates NK cell hyperresponsiveness and influenza-induced pathologies in a mouse model of chronic obstructive pulmonary disease. J Immunol 188: 4468-4475. doi:10.4049/jimmunol.1102643. PubMed: 22467655.
6. Orr MT, Lanier LL, (2010) Natural killer cell education and tolerance. Cell 142: 847-856. doi:10.1016/j.cell.2010.08.031. PubMed: 20850008.
7. Raulet DH, (2003) Roles of the NKG2D immunoreceptor and its ligands. Nat Rev Immunol 3: 781-790. doi:10.1038/nri1199. PubMed: 14523385.
8. Borchers MT, Harris NL, Wesselkamper SC, Vitucci M, Cosman D, (2006) NKG2D ligands are expressed on stressed human airway epithelial cells. Am J Physiol Lung Cell Mol Physiol 291: L222-L231. doi:10.1152/ajplung.00327.2005. PubMed: 16473864.
9. Kawai T, Akira S, (2006) Innate immune recognition of viral infection. Nat Immunol 7: 131-137. doi:10.1038/ni1303. PubMed: 16424890.
10. Kanneganti TD, Lamkanfi M, Núñez G, (2007) Intracellular NOD-like receptors in host defense and disease. Immunity 27: 549-559. doi:10.1016/j.immuni.2007.10.002. PubMed: 17967410.
11. Lucas M, Schachterle W, Oberle K, Aichele P, Diefenbach A, (2007) Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity 26: 503-517. doi:10.1016/j.immuni.2007.03.006. PubMed: 17398124.
12. Biron CA, Nguyen KB, Pien GC, Cousens LP, Salazar-Mather TP, (1999) Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol 17: 189-220. doi:10.1146/annurev.immunol.17.1.189. PubMed: 10358757.
13. Strowig T, Brilot F, Münz C, (2008) Noncytotoxic functions of NK cells: direct pathogen restriction and assistance to adaptive immunity. J Immunol 180: 7785-7791. PubMed: 18523242.
14. Ehlers M, Ravetch JV, (2007) Opposing effects of Toll-like receptor stimulation induce autoimmunity or tolerance. Trends Immunol 28: 74-79. doi:10.1016/j.it.2006.12.006. PubMed: 17197239.
15. Murray LA, Knight DA, McAlonan L, Argentieri R, Joshi A, et al. (2008) Deleterious role of TLR3 during hyperoxia-induced acute lung injury. Am J Respir Crit Care Med 178: 1227-1237. doi:10.1164/rccm.200807-1020OC. PubMed: 18849495.
16. Tabeta K, Hoebe K, Janssen EM, Du X, Georgel P, et al. (2006) The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9. Nat Immunol 7: 156-164. doi:10.1038/nrm1901. PubMed: 16415873.
17. Guerra N, Tan YX, Joncker NT, Choy A, Gallardo F, et al. (2008) NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy. Immunity 28: 571-580. doi:10.1016/j.immuni.2008.02.016. PubMed: 18394936.
18. Motz GT, Eppert BL, Sun G, Wesselkamper SC, Linke MJ, et al. (2008) Persistence of Lung CD8 T Cell Oligoclonal Expansions upon Smoking Cessation in a Mouse Model of Cigarette Smoke-Induced Emphysema. J Immunol 181: 8036-8043. PubMed: 19017996.
19. Wikenheiser KA, Vorbroker DK, Rice WR, Clark JC, Bachurski CJ, et al. (1993) Production of immortalized distal respiratory epithelial cell lines from surfactant protein C/simian virus 40 large tumor antigen transgenic mice. Proc Natl Acad Sci U S A 90: 11029-11033. doi:10.1073/pnas.90.23.11029. PubMed: 8248207.
20. Motz GT, Eppert BL, Wesselkamper SC, Flury JL, Borchers MT, (2010) Chronic Cigarette Smoke Exposure Generates Pathogenic T Cells Capable of Driving COPD-like Disease in Rag2-/- Mice. Am J Respir Crit Care Med 181: 1223-1233. PubMed: 20133926.
21. Lyerla TA, Rusiniak ME, Borchers M, Jahreis G, Tan J, et al. (2003) Aberrant lung structure, composition, and function in a murine model of Hermansky-Pudlak syndrome. Am J Physiol Lung Cell Mol Physiol 285: L643-L653. PubMed: 12777251.
22. Eppert BL, Wortham BW, Flury JL, Borchers MT, (2013) Functional characterization of T cell populations in a mouse model of chronic obstructive pulmonary disease. J Immunol 190: 1331-1340. doi:10.4049/jimmunol.1202442. PubMed: 23264660.
23. Hamerman JA, Ogasawara K, Lanier LL, (2004) Cutting edge: toll-like receptor signaling in macrophages induces ligands for the NKG2D receptor. J Immunol 172: 2001-2005. PubMed: 14764662.
24. Karikó K, Ni H, Capodici J, Lamphier M, Weissman D, (2004) mRNA is an endogenous ligand for Toll-like receptor 3. J Biol Chem 279: 12542-12550. PubMed: 14729660.
25. Vollmer J, Tluk S, Schmitz C, Hamm S, Jurk M, et al. (2005) Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8. J Exp Med 202: 1575-1585. doi:10.1084/jem.20051696. PubMed: 16330816.
26. Boulé MW, Broughton C, Mackay F, Akira S, Marshak-Rothstein A, et al. (2004) Toll-like receptor 9-dependent and-independent dendritic cell activation by chromatin-immunoglobulin G complexes. J Exp Med 199: 1631-1640. doi:10.1084/jem.20031942. PubMed: 15197227.
27. Bals R, Hiemstra PS, (2004) Innate immunity in the lung: how epithelial cells fight against respiratory pathogens. Eur Respir J 23: 327-333. doi:10.1183/09031936.03.00098803. PubMed: 14979512.
28. Vayssier M, Banzet N, François D, Bellmann K, Polla BS, (1998) Tobacco smoke induces both apoptosis and necrosis in mammalian cells: differential effects of HSP70. Am J Physiol 275: L771-L779. PubMed: 9755110.
29. Kode A, Yang SR, Rahman I, (2006) Differential effects of cigarette smoke on oxidative stress and proinflammatory cytokine release in primary human airway epithelial cells and in a variety of transformed alveolar epithelial cells. Respir Res 7: 132. doi:10.1186/1465-9921-7-132. PubMed: 17062156.
30. Kang MJ, Lee CG, Lee JY, Dela Cruz CS, Chen ZJ, et al. (2008) Cigarette smoke selectively enhances viral PAMP- and virus-induced pulmonary innate immune and remodeling responses in mice. J Clin Invest 118: 2771-2784. PubMed: 18654661.
31. Wang Z, Zheng T, Zhu Z, Homer RJ, Riese RJ, et al. (2000) Interferon gamma induction of pulmonary emphysema in the adult murine lung. J Exp Med 192: 1587-1600. doi:10.1084/jem.192.11.1587. PubMed: 11104801.
32. Hodge S, Hodge G, Holmes M, Reynolds PN, (2005) Increased airway epithelial and T-cell apoptosis in COPD remains despite smoking cessation. Eur Respir J 25: 447-454. doi:10.1183/09031936.05.00077604. PubMed: 15738287.
33. Groh V, Bruhl A, El-Gabalawy H, Nelson JL, Spies T, (2003) Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis. Proc Natl Acad Sci U S A 100: 9452-9457. doi:10.1073/pnas.1632807100. PubMed: 12878725.
34. Schrambach S, Ardizzone M, Leymarie V, Sibilia J, Bahram S, (2007) In vivo expression pattern of MICA and MICB and its relevance to auto-immunity and cancer. PLOS ONE 2: e518. doi:10.1371/journal.pone.0000518. PubMed: 17565371.
35. Hüe S, Monteiro RC, Berrih-Aknin S, Caillat-Zucman S, (2003) Potential role of NKG2D/MHC class I-related chain A interaction in intrathymic maturation of single-positive CD8 T cells. J Immunol 171: 1909-1917. PubMed: 12902493.
36. Ogasawara K, Hamerman JA, Ehrlich LR, Bour-Jordan H, Santamaria P, et al. (2004) NKG2D blockade prevents autoimmune diabetes in NOD mice. Immunity 20: 757-767. doi:10.1016/j.immuni.2004.05.008. PubMed: 15189740.
37. Zhou R, Wei H, Sun R, Zhang J, Tian Z, (2007) NKG2D recognition mediates Toll-like receptor 3 signaling-induced breakdown of epithelial homeostasis in the small intestines of mice. Proc Natl Acad Sci U S A 104: 7512-7515. doi:10.1073/pnas.0700822104. PubMed: 17463084.
38. Goh FG, Midwood KS, (2012) Intrinsic danger: activation of Toll-like receptors in rheumatoid arthritis. Rheumatology (Oxford) 51: 7-23. doi:10.1093/rheumatology/ker257. PubMed: 21984766.
39. Brentano F, Schorr O, Gay RE, Gay S, Kyburz D, (2005) RNA released from necrotic synovial fluid cells activates rheumatoid arthritis synovial fibroblasts via Toll-like receptor 3. Arthritis Rheum 52: 2656-2665. doi:10.1002/art.21273. PubMed: 16142732.
40. Wong FS, Hu C, Zhang L, Du W, Alexopoulou L, et al. (2008) The role of Toll-like receptors 3 and 9 in the development of autoimmune diabetes in NOD mice. Ann N Y Acad Sci 1150: 146-148. doi:10.1196/annals.1447.039. PubMed: 19120284.